Letter to Editor
Synthetic Biology and Risk: Is this Really an Ethical Dilema?
Beriain I de M*
Interuniversity Chair in Law and the Human Genome, University of the Basque, Bilbao, Spain
- *Corresponding Author:
- Iñigo de Miguel Beriain
Interuniversity Chair in Law
and the Human Genome
University of the Basque, Bilbao, Spain
Email: [email protected]
Received date: April 14, 2015, Accepted date: April 23, 2015, Published date: April 26, 2015
Citation: Beriain I de M (2015) Synthetic Biology and Risk: Is this Really an Ethical Dilema? Beriain, Curr Synthetic Sys Biol 3:120. doi:10.4172/2332-0737.1000120
Copyright: © 2015 Beriain I de M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
We live in troubled times, when the evolution of biology is following a bewildering pace. If a few years ago we were all surprised by the speed with which the human genome was decoded, nowadays it is more than possible that many of the challenges that even at that point seemed complex to face are within our reach. The most accurate example might come from the field of genetic engineering. Ten years ago, its general application seemed to be quite far from reality. However, it is currently a possibility that is about to come true thanks to the CRISPR/Cas9 technology. Synthetic biology is not an exception to this universal trend. The latest scientific advances, such as the redesign and production of a fully functional chromosome extracted from baker’s yeast (Saccharomyces cerevisiae) are evidence that we are very close to startling developments in a very near future.